Your browser doesn't support javascript.
loading
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Ishihara, Mikiya; Nishida, Yoshihiro; Kitano, Shigehisa; Kawai, Akira; Muraoka, Daisuke; Momose, Fumiyasu; Harada, Naozumi; Miyahara, Yoshihiro; Seo, Naohiro; Hattori, Hiroyoshi; Takada, Kohichi; Emori, Makoto; Kakunaga, Shigeki; Endo, Makoto; Matsumoto, Yoshihiro; Sasada, Tetsuro; Sato, Eiichi; Yamada, Tomomi; Matsumine, Akihiko; Nagata, Yasuhiro; Watanabe, Takashi; Kageyama, Shinichi; Shiku, Hiroshi.
Afiliación
  • Ishihara M; Cancer Center, Mie University Hospital, Tsu, Japan.
  • Nishida Y; Department of Rehabilitation, Nagoya University Hospital, Nagoya, Japan.
  • Kitano S; Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kawai A; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Muraoka D; Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
  • Momose F; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Harada N; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
  • Miyahara Y; United Immunity, Co., Ltd., Tokyo, Japan.
  • Seo N; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
  • Hattori H; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
  • Takada K; Laboratory of Advanced Therapy, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Emori M; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kakunaga S; Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Endo M; Department of Orthopaedic Surgery, Osaka National Hospital, Osaka, Japan.
  • Matsumoto Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Sasada T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Sato E; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Yamada T; Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
  • Matsumine A; Department of Medical Innovation, Osaka University Hospital, Suita, Japan.
  • Nagata Y; Department of Orthopaedics and Rehabilitation Medicine, Unit of Surgery, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Yoshida-gun, Japan.
  • Watanabe T; Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kageyama S; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
  • Shiku H; Department of Immuno-Gene therapy, Mie University Graduate School of Medicine, Tsu, Japan.
Int J Cancer ; 152(12): 2554-2566, 2023 06 15.
Article en En | MEDLINE | ID: mdl-36727538
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Tejidos Blandos / Neoplasias Esofágicas / Vacunas / Sarcoma Sinovial / Carcinoma de Células Escamosas de Esófago Límite: Animals Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Tejidos Blandos / Neoplasias Esofágicas / Vacunas / Sarcoma Sinovial / Carcinoma de Células Escamosas de Esófago Límite: Animals Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón